Figure 4
From: A novel multidrug-resistant cell line from a Chinese patient with pancreatic ductal adenocarcinoma
Assessment of anti-cancer drug sensitivity in PDAC-X2 cells (P40 and P70), PANC-1 cells, and BxPC-3 cells. PDAC-X2 cells (P40 and P70) demonstrated resistance to oxaliplatin (A), 5-fluorouracil (5-FU) (B), gemcitabine (C) and paclitaxel (D); PANC-1 demonstrated resistance to oxaliplatin (A); gemcitabine (C); paclitaxel (D); and sensitiveness to fluorouracil (B). BxPC-3 demonstrated sensitiveness to oxaliplatin (A); fluorouracil (B); paclitaxel (D); and resistance to gemcitabine (C).
